Clinical Oral Pathology and Medicine: An update on the diagnosis, etiology and pathogenesis and treatment of important and/or commonly encountered oral lesions.

DATE: Oct. 7-14, 2006

LOCATION: Canada/New England Cruise aboard the Star Princess - Princess Cruise Lines (Port - New York)

REGISTRATION FEE: $459 per participant, $359 each additional participant from same office (in addition to the cruise prices)

CRUISE PRICING: Inside Cabins starting @ $1,135 pp. Port and government fees additional $140.96 pp.

COURSE DESCRIPTION: Using a case study, lecture and participatory approach, this seminar will review and update dental practitioners and auxiliaries on the subject of clinical oral pathology and medicine. Emphasis will be placed on lesions commonly seen in dental practice especially those difficult to diagnose and/or manage, premalignant or malignant lesions and newly described entities especially bisphosphonate induced osteochemonecrosis. Also included will be a discussion of recent developments in determining the etiology and especially treatment and prevention of oral cancer and premalignant lesions such as leukoplakia. Included in this will be a discussion of the newest most important predictors of oral cancer development, ploidy and proliferative verrucous hyperplasia as well as the critical genetic alterations and the newly delineated role for human papilloma virus infection in oral cancer. Specific topics include burning mouth syndrome, contact stomatitis, a new paradigm in diagnosing and treating oral ulcers and drug induced ulcers and allergies, pigmentations and gingival hyperplasia.

COURSE OBJECTIVES:
The participant will be able to:

• Improve the clinician’s ability to recognize, categorize and treat lesions of the head and neck.
• Broaden the practitioner’s differential diagnoses to include some new and/or unrecognized lesions.
• Make clinicians aware of new treatment modalities for some of the common and troublesome lesions of the oral soft tissues.
• Understand why we often fail at treating these lesions and how to regroup and successfully incorporate oral medicine into our practice.
• Recognize the oral manifestations of adverse drug reactions and how to attack this problem.
• Learn how to prevent and manage patients with bisphosphonate induced osteochemonecrosis.
• Become up to date on the new developments in the etiology, pathogenesis and prevention of oral cancer.
• Learn about the new predictors of oral cancer development (high risk HPV, ploidy and proliferative verrucous hyperplasia).

FACULTY: Don Cohen, D.M.D., M.S., MBA, Professor, Oral & Maxillofacial Surgery & Diagnostic Sciences.

CONTINUING EDUCATION UNITS: 12 contact hours. Lecture.

Call toll free 1-888-550-4590 for details and to Register!